Select Medical (SEM) reported Q1 earnings from continuing operations late Thursday of $0.44 per diluted share, up from $0.33 a year earlier.
Analysts polled by FactSet expected $0.46.
Revenue for the quarter ended March 31 was $1.35 billion compared with $1.32 billion a year earlier.
Analysts surveyed by FactSet expected $1.39 billion.
The company reaffirmed its 2025 earnings of $1.09 to $1.19 per diluted share. Analysts surveyed by FactSet expect $1.12. The company Trimmed annual revenue guidance to $5.3 billion to $5.5 billion from $5.4 billion to $5.6 billion. Analysts polled by FactSet expect $5.46 billion.
Shares of the company fell more than 3% in recent premarket activity.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。